CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for NERVGEN PHARMA CORP. · Medical, pharma

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000.00 income · posted Apr 8, 2026

Lobbying activity 3

Veterans

Legislation related to spinal cord injury research and treatment.

Defense

Legislation related to central nervous system research and therapeutics.

Health Issues

Legislation related to spinal cord injury research, therapeutics and approvals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.